Dipexium Pharmaceuticals Inc.

Dipexium Pharmaceuticals Inc. is a late-stage pharmaceutical company focused on the development and commercialization of Locilex (pexiganan cream 0.8%), a potent and broad-spectrum topical antibiotic peptide for the treatment of mild and moderate skin-and skin-structure infections.